These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26951819)

  • 1. CXCR2 Mediates Brucella-Induced Arthritis in Interferon γ-Deficient Mice.
    Lacey CA; Keleher LL; Mitchell WJ; Brown CR; Skyberg JA
    J Infect Dis; 2016 Jul; 214(1):151-60. PubMed ID: 26951819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal Role for MyD88 in a Model of Brucella-Induced Arthritis and Musculoskeletal Inflammation.
    Lacey CA; Mitchell WJ; Brown CR; Skyberg JA
    Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28069819
    [No Abstract]   [Full Text] [Related]  

  • 3. IFN-γ-deficient mice develop IL-1-dependent cutaneous and musculoskeletal inflammation during experimental brucellosis.
    Skyberg JA; Thornburg T; Kochetkova I; Layton W; Callis G; Rollins MF; Riccardi C; Becker T; Golden S; Pascual DW
    J Leukoc Biol; 2012 Aug; 92(2):375-87. PubMed ID: 22636321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal vaccination stimulates CD8(+) T cells for potent protection against mucosal Brucella melitensis challenge.
    Clapp B; Yang X; Thornburg T; Walters N; Pascual DW
    Immunol Cell Biol; 2016 May; 94(5):496-508. PubMed ID: 26752510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-γ-dependent nitric oxide suppresses Brucella-induced arthritis by inhibition of inflammasome activation.
    Lacey CA; Chambers CA; Mitchell WJ; Skyberg JA
    J Leukoc Biol; 2019 Jul; 106(1):27-34. PubMed ID: 30748031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice.
    Vitry MA; De Trez C; Goriely S; Dumoutier L; Akira S; Ryffel B; Carlier Y; Letesson JJ; Muraille E
    Infect Immun; 2012 Dec; 80(12):4271-80. PubMed ID: 23006848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
    Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen.
    Machelart A; Khadrawi A; Demars A; Willemart K; De Trez C; Letesson JJ; Muraille E
    Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28808159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
    Al-Mariri A; Abbady AQ
    J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MyD88-dependent activation of B220-CD11b+LY-6C+ dendritic cells during Brucella melitensis infection.
    Copin R; De Baetselier P; Carlier Y; Letesson JJ; Muraille E
    J Immunol; 2007 Apr; 178(8):5182-91. PubMed ID: 17404301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice.
    Zhang Y; Li T; Zhang J; Li Z; Zhang Y; Wang Z; Feng H; Wang Y; Chen C; Zhang H
    World J Microbiol Biotechnol; 2016 Apr; 32(4):58. PubMed ID: 26925620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T cell exhaustion, suppressed gamma interferon production, and delayed memory response induced by chronic Brucella melitensis infection.
    Durward-Diioia M; Harms J; Khan M; Hall C; Smith JA; Splitter GA
    Infect Immun; 2015 Dec; 83(12):4759-71. PubMed ID: 26416901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MyD88-Dependent Glucose Restriction and Itaconate Production Control Brucella Infection.
    Lacey CA; Ponzilacqua-Silva B; Chambers CA; Dadelahi AS; Skyberg JA
    Infect Immun; 2021 Sep; 89(10):e0015621. PubMed ID: 34125603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nramp1 is not a major determinant in the control of Brucella melitensis infection in mice.
    Guilloteau LA; Dornand J; Gross A; Olivier M; Cortade F; Vern YL; Kerboeuf D
    Infect Immun; 2003 Feb; 71(2):621-8. PubMed ID: 12540538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice.
    N T; B N; O O; D D; J B
    BMC Complement Altern Med; 2018 May; 18(1):144. PubMed ID: 29724202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of protective immunity against brucellosis in mice by vaccination with a combination of naloxone, alum, and heat-killed Brucella melitensis 16 M.
    Motaharinia Y; Rezaee MA; Rashidi A; Jalili A; Rezaie MJ; Shapouri R; Hossieni W; Rahmani MR
    J Microbiol Immunol Infect; 2013 Aug; 46(4):253-8. PubMed ID: 22727892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immunity and CD4+ Th1 cells are both necessary for a fully protective immune response upon secondary infection with Brucella melitensis.
    Vitry MA; Hanot Mambres D; De Trez C; Akira S; Ryffel B; Letesson JJ; Muraille E
    J Immunol; 2014 Apr; 192(8):3740-52. PubMed ID: 24646742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Immune Effectors Essential to the Control of Primary and Secondary Intranasal Infection with Brucella melitensis in Mice.
    Hanot Mambres D; Machelart A; Potemberg G; De Trez C; Ryffel B; Letesson JJ; Muraille E
    J Immunol; 2016 May; 196(9):3780-93. PubMed ID: 27036913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.
    Abkar M; Amani J; Sahebghadam Lotfi A; Nikbakht Brujeni G; Alamian S; Kamali M
    APMIS; 2015 Aug; 123(8):667-75. PubMed ID: 25939375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.